-
Assessing the Cost-Effectiveness of Lecanemab for Early Alzheimer's Disease Treatment: A Swiss Perspective
Sep 9, 2025, 16:22 PM -
The Impact of Delaying Access to Innovative Therapies in Emerging Markets for Chronic Lymphocytic Leukemia: A Modeling Study
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Pancreatic Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Hybrid Digital Support for Patients Receiving Biosimilar-Adalimumab Therapy for Immune-Mediated Inflammatory Disorders: 12-Month Persistence and Impact on Adherence
Sep 9, 2025, 16:22 PM -
The Growing Role of Real-World Evidence (RWE) to Support Efficacy in EMA Oncology Approvals: Light at the End of the Tunnel
Sep 9, 2025, 16:22 PM -
Optimizing Patient Retention in Non–Site-Based Longitudinal Studies: Tailored Follow-up Strategies for Rare Disease Cohorts
Sep 9, 2025, 16:22 PM -
Limited Duration vs. Treat-to-Progression Approaches for New Therapies in Hemato-oncology: Impact at HTA
Sep 9, 2025, 16:22 PM -
Mind the Gap: A Need for Guidance on Modeling Disease Activity Outcomes in Economic Models
Sep 9, 2025, 16:22 PM -
Structured Expert Elicitation for Survival Outcomes: Insights From NICE Technical Support Document 26
Sep 9, 2025, 16:22 PM -
Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models
Sep 9, 2025, 16:22 PM -
Cost Savings From Patient Preference-Based Allocation of High-Efficacy Therapies for MS: Evidence From Switzerland
Sep 9, 2025, 16:22 PM -
Factors Influencing Intent to Vaccinate Against Respiratory Syncytial Virus (RSV) Among Older Adults in Australia, Hong Kong, Japan, New Zealand, South Korea, Singapore, and Taiwan
Sep 9, 2025, 16:22 PM -
Trends and Disparities in Prostate Cancer Incidence Prevalence and Survival: A SEER Analysis 2000-2022
Sep 9, 2025, 16:22 PM -
Feasibility of Indication-Specific Pricing for Life Cycle Management of an Innovative Rare Disease Product
Sep 9, 2025, 16:22 PM -
Site-Specific Wastewater-Based Surveillance in Early Detection of COVID-19 New Cases and Prediction of Mass Testing Outcomes in Long-Term Care Facilities
Sep 9, 2025, 16:22 PM -
Understanding Public Values in Digital Mental Health Using the Principles, Policies, and Patients’ Framework
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of STRIDE (Tremelimumab + Durvalumab) vs. Atezolizumab + Bevacizumab for Unresectable Hepatocellular Carcinoma: Qatari Payer and Societal Perspectives
Sep 9, 2025, 16:22 PM -
A Scoping Review of Resource Modeling in HTA Using Discrete Event Simulation
Sep 9, 2025, 16:22 PM -
Prefilled Syringes in Anesthesiology: A Quantitative Assessment of Economic and Organizational Outcomes
Sep 9, 2025, 16:22 PM -
Preliminary Real-World Comparative Analysis of Trastuzumab Deruxtecan vs. Trastuzumab Emtansine in Second-Line HER2-Positive Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM
